Centerpoint Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$175K Hold
4,000
– – 0.05% 99
2026
Q2
$171K Hold
4,000
– – 0.05% 94
2026
Q1
$251K Hold
4,000
– – 0.08% 75
2025
Q4
$381K Hold
4,000
– – 0.12% 67
2025
Q3
$391K Hold
4,000
– – 0.12% 66
2025
Q2
$430K Hold
4,000
– – 0.15% 55
2025
Q1
$404K Hold
4,000
– – 0.15% 56
2024
Q4
$357K Hold
4,000
– – 0.13% 64
2024
Q3
$335K Hold
4,000
– – 0.12% 66
2024
Q2
$308K Hold
4,000
– – 0.11% 68
2024
Q1
$274K Hold
4,000
– – 0.1% 75
2023
Q4
$231K Sell
4,000
-18
-0.4% -$961 0.09% 78
2023
Q3
$212K Hold
4,018
– – 0.09% 86
2023
Q2
$217K Hold
4,018
– – 0.09% 84
2023
Q1
$201K Buy
4,018
+18
+0.5% +$848 0.09% 97
2022
Q4
$185K Sell
4,000
-94
-2% -$4.07K 0.09% 90
2022
Q3
$159K Hold
4,094
– – 0.08% 89
2022
Q2
$153K Hold
4,094
– – 0.08% 93
2022
Q1
$181K Hold
4,094
– – 0.08% 90
2021
Q4
$174K Hold
4,094
– – 0.08% 93
2021
Q3
$178K Hold
4,094
– – 0.08% 91
2021
Q2
$175K Buy
4,094
+4,000
+4,255% +$168K 0.08% 94
2021
Q1
$4K Hold
94
– – ﹤0.01% 211
2020
Q4
$3K Hold
94
– – ﹤0.01% 206
2020
Q3
$4K Hold
94
– – ﹤0.01% 192
2020
Q2
$3K Hold
94
– – ﹤0.01% 233
2020
Q1
$3K Hold
94
– – ﹤0.01% 206
2019
Q4
$4K Hold
94
– – ﹤0.01% 219
2019
Q3
$4K Hold
94
– – ﹤0.01% 206
2019
Q2
$4K Hold
94
– – ﹤0.01% 198
2019
Q1
$4K Hold
94
– – ﹤0.01% 191
2018
Q4
$3K Hold
94
– – ﹤0.01% 196
2018
Q3
$4K Hold
94
– – ﹤0.01% 181
2018
Q2
$3K Buy
94
+61
+185% +$1.84K ﹤0.01% 237
2018
Q1
$1K Buy
+33
New +$897 ﹤0.01% 225

Other funds holding BSX

Centerpoint Advisors's BSX Position: Q3 2026 in Review

Centerpoint Advisors held its Boston Scientific (BSX) position steady in Q3 2026 at 4,000 shares worth $175K. The position accounts for 0.05% of the portfolio, ranked #99.

Centerpoint Advisors first reported a position in BSX in Q1 2018 and has held it in 35 quarters since. The position peaked at $430K in Q2 2025. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Centerpoint Advisors held 4,000 shares of Boston Scientific worth $175K as of Q3 2026.
  • Centerpoint Advisors left its Boston Scientific share count unchanged in Q3 2026.
  • Boston Scientific made up 0.05% of Centerpoint Advisors's portfolio in Q3 2026, its #99 holding.
  • Centerpoint Advisors first reported a position in Boston Scientific in Q1 2018 and has held it in 35 quarters since.
  • Centerpoint Advisors's Boston Scientific position peaked at $430K in Q2 2025.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Centerpoint Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.